(Post-pandemic Era)-Global Gadolinium-Based Contrast Agents Market Segment Research Report 2022
- Published Date: 2022-04-19
- Report ID: 127851
- Pages: 175
-
Format:
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Gadolinium-Based Contrast Agents Market Segment Research Report 2022, which aims to sort out the development status and trends of the Gadolinium-Based Contrast Agents industry at home and abroad, estimate the overall market scale of the Gadolinium-Based Contrast Agents industry and the market share of major countries, analyze the development potential of each segment of the Gadolinium-Based Contrast Agents industry, and study and judge the downstream market demand of Gadolinium-Based Contrast Agents through systematic research, Analyze the competition pattern of Gadolinium-Based Contrast Agents, so as to help solve the pain points of various stakeholders in Gadolinium-Based Contrast Agents industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Gadolinium-Based Contrast Agents Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Gadolinium-Based Contrast Agents Market
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary
Major Type of Gadolinium-Based Contrast Agents Covered in XYZResearch report:
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Application Segments Covered in XYZResearch Market
Hospital
Specialist Clinic
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Gadolinium-Based Contrast Agents Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Gadolinium-Based Contrast Agents Market by Value
2.2.1 Global Gadolinium-Based Contrast Agents Revenue by Type
2.2.2 Global Gadolinium-Based Contrast Agents Market by Value (%)
2.3 Global Gadolinium-Based Contrast Agents Market by Production
2.3.1 Global Gadolinium-Based Contrast Agents Production by Type
2.3.2 Global Gadolinium-Based Contrast Agents Market by Production (%)
3. The Major Driver of Gadolinium-Based Contrast Agents Industry
3.1 Historical & Forecast Global Gadolinium-Based Contrast Agents Demand
3.2 Largest Application for Gadolinium-Based Contrast Agents (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Gadolinium-Based Contrast Agents Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Gadolinium-Based Contrast Agents Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Gadolinium-Based Contrast Agents Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Gadolinium-Based Contrast Agents Average Price Trend
12.1 Market Price for Each Type of Gadolinium-Based Contrast Agents in US (2018-2022)
12.2 Market Price for Each Type of Gadolinium-Based Contrast Agents in Europe (2018-2022)
12.3 Market Price for Each Type of Gadolinium-Based Contrast Agents in China (2018-2022)
12.4 Market Price for Each Type of Gadolinium-Based Contrast Agents in Japan (2018-2022)
12.5 Market Price for Each Type of Gadolinium-Based Contrast Agents in India (2018-2022)
12.6 Market Price for Each Type of Gadolinium-Based Contrast Agents in Korea (2018-2022)
12.7 Market Price for Each Type of Gadolinium-Based Contrast Agents in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Gadolinium-Based Contrast Agents Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Gadolinium-Based Contrast Agents
14. Gadolinium-Based Contrast Agents Competitive Landscape
14.1 GE Healthcare
14.1.1 GE Healthcare Company Profiles
14.1.2 GE Healthcare Product Introduction
14.1.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Bayer
14.2.1 Bayer Company Profiles
14.2.2 Bayer Product Introduction
14.2.3 Bayer Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bracco Imaging
14.3.1 Bracco Imaging Company Profiles
14.3.2 Bracco Imaging Product Introduction
14.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Guerbet Group
14.4.1 Guerbet Group Company Profiles
14.4.2 Guerbet Group Product Introduction
14.4.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Hengrui Medicine
14.5.1 Hengrui Medicine Company Profiles
14.5.2 Hengrui Medicine Product Introduction
14.5.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Lantheus
14.6.1 Lantheus Company Profiles
14.6.2 Lantheus Product Introduction
14.6.3 Lantheus Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 YRPG
14.7.1 YRPG Company Profiles
14.7.2 YRPG Product Introduction
14.7.3 YRPG Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 BeiLu Pharma
14.8.1 BeiLu Pharma Company Profiles
14.8.2 BeiLu Pharma Product Introduction
14.8.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Jiangsu Hengrui Medicine
14.9.1 Jiangsu Hengrui Medicine Company Profiles
14.9.2 Jiangsu Hengrui Medicine Product Introduction
14.9.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Marotrast
14.10.1 Marotrast Company Profiles
14.10.2 Marotrast Product Introduction
14.10.3 Marotrast Gadolinium-Based Contrast Agents Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Agfa
14.12 Stary
15. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
